KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Other Non-Current Assets (2016 - 2025)

Gilead Sciences' Other Non-Current Assets history spans 17 years, with the latest figure at $4.8 billion for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 28.55% year-over-year to $4.8 billion; the TTM value through Dec 2025 reached $4.8 billion, up 28.55%, while the annual FY2025 figure was $4.8 billion, 28.55% up from the prior year.
  • Other Non-Current Assets reached $4.8 billion in Q4 2025 per GILD's latest filing, down from $4.9 billion in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $5.6 billion in Q2 2021 to a low of $3.8 billion in Q4 2024.
  • Average Other Non-Current Assets over 5 years is $4.8 billion, with a median of $4.9 billion recorded in 2022.
  • Peak YoY movement for Other Non-Current Assets: soared 30.81% in 2024, then dropped 25.39% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $5.0 billion in 2021, then dropped by 3.28% to $4.8 billion in 2022, then fell by 0.17% to $4.8 billion in 2023, then fell by 21.35% to $3.8 billion in 2024, then increased by 28.55% to $4.8 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Other Non-Current Assets are $4.8 billion (Q4 2025), $4.9 billion (Q3 2025), and $4.0 billion (Q2 2025).